Ceftriaxon Lagap 500 mg i.v.

Ceftriaxon Lagap 500 mg i.v. is a medicine authorised by Swissmedic under authorisation number 68535. The authorisation holder is Lagap SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 24 November 2022 and the authorisation is limited until 23 November 2027. ATC code J01DD04 places the medicine in the group Antibacterials for systemic use.

  • Dispensing category A
  • Authorisation number 68535
  • ATC J01DD04
  • Synthetic medicines
Authorisation data
Authorisation number68535
NameCeftriaxon Lagap 500 mg i.v.
Full nameCeftriaxon Lagap 500 mg i.v., Polvere per soluzione iniettabile
Authorisation holderLagap SA
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeJ01DD04
First authorisation24 November 2022
Authorisation validity23 November 2027
Strengths
No.NameDispensing categoryAuthorisation date
1Ceftriaxon Lagap 500 mg i.v., Polvere per soluzione iniettabileA24 November 2022
2Ceftriaxon Lagap 1000 mg i.v./i.m., Polvere per soluzione iniettabileA24 November 2022
3Ceftriaxon Lagap 2000 mg i.v., Polvere per soluzione per infusioneA24 November 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)J01DD0408.01.A
210Durchstechflasche(n)J01DD0408.01.A
31Durchstechflasche(n)J01DD0408.01.A
410Durchstechflasche(n)J01DD0408.01.A
51Durchstechflasche(n)J01DD0408.01.A
610Durchstechflasche(n)J01DD0408.01.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ceftriaxon Lagap 500 mg i.v. authorised in Switzerland?

Yes. Ceftriaxon Lagap 500 mg i.v. is authorised by Swissmedic under authorisation number 68535, data as of 01 September 2026. The authorisation is limited until 23 November 2027.

Which dispensing category does Ceftriaxon Lagap 500 mg i.v. have?

Ceftriaxon Lagap 500 mg i.v. is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Ceftriaxon Lagap 500 mg i.v.?

The authorisation holder is Lagap SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com